Contract 36F79723D0223
Gamida Cell Inc · Department Of Veterans Affairs · October 28, 2025
Gamida Cell Inc was awarded a federal contract by Department Of Veterans Affairs on October 28, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 23, 2025. If all options are exercised, the contract could reach $255,000.
Contract details
- PIID
- 36F79723D0223
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- October 28, 2025
- Latest action
- December 23, 2025
Description
NDC CHANGE
Modification timeline
-
December 23, 2025Mod P00007 · Supplemental Agreement For Work Within Scope$0
-
December 2, 2025Mod P00006 · Supplemental Agreement For Work Within Scope2026 PUBLIC LAW$0
-
October 28, 2025Mod P00005 · Other Administrative ActionPOC CHANGE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79723D0223?
Contract 36F79723D0223 is a federal contract awarded to Gamida Cell Inc by Department Of Veterans Affairs on October 28, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36F79723D0223?
Gamida Cell Inc won contract 36F79723D0223 from Department Of Veterans Affairs.
How much is contract 36F79723D0223 worth?
Contract 36F79723D0223 has obligated $0 to date but carries a potential ceiling of $255,000 if fully funded and all options are exercised.